Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 55 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

4%

1 of 27 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

51Total
Not Applicable (49)
P 1 (1)
P 2 (1)

Trial Status

Completed27
Unknown12
Recruiting9
Not Yet Recruiting3
Enrolling By Invitation2
Active Not Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (55)

Showing 20 of 20 trials
NCT04607096Not ApplicableRecruiting

Intermittent Fasting to Improve Insulin Secretion

NCT07513116Not ApplicableNot Yet Recruiting

Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening

NCT07481513Not ApplicableRecruiting

Impact of Intermittent Fasting on the Mental Health of Perimenopausal Women

NCT06019195Not ApplicableCompletedPrimary

The Effect of Intermittent Fasting on Brain Health

NCT04899102Not ApplicableRecruiting

Intermittent Fasting for NAFLD in Adults

NCT06013761Not ApplicableCompleted

IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy

NCT07055620Not ApplicableCompleted

Effects of Different Dietary Models on Eating Behavior and Obesity Management in Overweight and Obese Individuals

NCT06766747Not ApplicableCompleted

Efficacy of Intermittent Fasting Versus Continuous Caloric Restriction in the Treatment of Significant Weight Regain After Bariatric Surgery

NCT07140289Enrolling By Invitation

Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) on Gastric Emptying

NCT06963437Not ApplicableCompleted

Interventions for Weight Regain After Bariatric Surgery

NCT06630637Not ApplicableCompletedPrimary

Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study

NCT06330610Not ApplicableRecruitingPrimary

Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit

NCT06664684Not ApplicableCompletedPrimary

Intermittent Fasting and Metabolic Dysfunction Associated Fatty Liver Disease

NCT07001358Active Not RecruitingPrimary

The Rufaida Project: Researching the Impact of Ramadan Fasting on the Gut and Vaginal Microbiome

NCT06959069Not ApplicableRecruiting

Impact of Intermittent Fasting on Sleep and Quality of Life

NCT06689436Phase 2Completed

Pivotal BE Study of TAH3311 ODF vs ELIQUIS® Tablet Under Fasted Condition in Healthy Volunteers

NCT06299020Not ApplicableCompleted

Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency

NCT06804044Not ApplicableCompleted

Intermittent Fasting (IF) Has Gained Recognition as a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic Benefits

NCT06323889Not ApplicableRecruitingPrimary

Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults

NCT06615817Not ApplicableNot Yet Recruiting

Intermittent Fasting, Mediterranean Diet and NAFLD

Scroll to load more

Research Network

Activity Timeline